HPC
NARI

HM Payson & Co’s Inari Medical, Inc. Common Stock NARI Stock Holding History

HM Payson & Co’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-179
Closed -$16K – 1169
2021
Q4 		$16K Buy
+179
New +$15.3K ﹤0.01% 809
2021
Q2 		– Sell
-142
Closed -$15K – 1192
2021
Q1 		$15K Buy
142
+123
+647% +$12.8K ﹤0.01% 822
2020
Q4 		$2K Sell
19
-5
-21% -$353 ﹤0.01% 1033
2020
Q3 		$2K Buy
+24
New +$1.54K ﹤0.01% 966

Other funds holding NARI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

HM Payson & Co's NARI Position: Q1 2022 in Review

HM Payson & Co sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2022, closing a stake of 179 shares — an estimated $16K sold.

HM Payson & Co first reported a position in NARI in Q3 2020 and held it in 4 quarters. The position peaked at $16K in Q4 2021. 214 funds tracked by Wall St. Rank hold NARI as of Q1 2022.

  • HM Payson & Co reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • HM Payson & Co sold 179 Inari Medical, Inc. Common Stock shares in Q1 2022, an estimated $16K.
  • HM Payson & Co first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • HM Payson & Co's Inari Medical, Inc. Common Stock position peaked at $16K in Q4 2021.
  • 214 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2022.

Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.